MIND MEDIA GROUP (NeuroLOGX B.V.)

Mind Media Group manufactures and supplies EEG-based neurotechnology platforms for clinical, research, and educational applications. The company's core product line is the NeXus system—a multimodal biosensor platform available in wireless configurations (NeXus 10 MK3, NeXus Q24, NeXus Q32)—designed for nervous system sensing and real-time biofeedback/neurofeedback training. NeXus integrates EEG acquisition with sensors for physiological measurement (heart rate variability, skin conductance, respiration) and connects to Biotrace+, proprietary software for quantitative EEG (qEEG), biofeedback protocols, and neurofeedback applications. The platform serves three primary markets: clinical practice (mind-body assessments, therapeutic training for PTSD, ADHD, anxiety, depression), research (3000+ peer-reviewed publications), and education (certification and practitioner development). Complementary offerings include EEG caps, sensors, and cables. The company is widely adopted by major medical centers (Mayo Clinic, Cleveland Clinic, Kaiser Permanente), military and VA health systems (Walter Reed, multiple VA facilities, Department of Defense), academic institutions (MIT, Harvard, Max Planck Institute), and specialized centers (Rady Children's Hospital, Schön Klinik). Mind Media provides comprehensive training and education through its Path to Mastery Academy, offering courses from biofeedback basics through certified practitioner certification. The platform supports clinical assessment, performance optimization, and neuroscience research. Regulatory status, ISO certifications, and FDA classification status are not explicitly stated in available content.